Marinus Pharmaceuticals Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
| Owner Type | Number of Shares | Ownership Percentage |
|---|---|---|
| Individual Insiders | 244,902 | 0.445% |
| VC/PE Firms | 4,151,576 | 7.54% |
| Hedge Funds | 7,799,617 | 14.2% |
| General Public | 11,483,135 | 20.8% |
| Institutions | 31,404,808 | 57% |
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
| Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
|---|---|---|---|---|---|---|
| 4,800,000 | US$8.4m | 0% | 0.72% | |||
| 4,151,576 | US$7.2m | 196% | 0.43% | |||
| 3,979,605 | US$6.9m | 235% | 0.06% | |||
| 3,820,012 | US$6.6m | -25.2% | 0.24% | |||
| 3,493,143 | US$6.1m | 0% | no data | |||
| 2,802,965 | US$4.9m | -0.11% | no data | |||
| 2,267,680 | US$3.9m | 62.8% | 0.4% | |||
| 2,114,827 | US$3.7m | -0.2% | 10.87% | |||
| 1,872,463 | US$3.3m | 0% | 0.82% | |||
| 1,869,949 | US$3.3m | -60.4% | no data | |||
| 1,469,285 | US$2.6m | -50.5% | no data | |||
| 1,080,198 | US$1.9m | 95.5% | no data | |||
| 718,580 | US$1.3m | 0% | no data | |||
| 706,154 | US$1.2m | 31.3% | 0.33% | |||
| 695,972 | US$1.2m | 0% | no data | |||
| 621,625 | US$1.1m | 0% | no data | |||
| 617,395 | US$1.1m | -49.2% | no data | |||
| 512,278 | US$891.4k | 404% | no data | |||
| 501,797 | US$873.1k | 383% | no data | |||
| 403,711 | US$702.5k | -14% | no data | |||
| 385,250 | US$670.3k | -1.33% | no data | |||
| 297,014 | US$516.8k | 600% | no data | |||
| 290,000 | US$504.6k | 0% | no data | |||
| 261,861 | US$455.6k | -53.7% | 0.54% | |||
| 260,789 | US$453.8k | -3.82% | no data |